The need for novel approaches to HIV-1 vaccine development - The Lancet Infectious Diseases thelancet.com/journals/lanin…

I'm honoured to be the first guest of the revamped IAS - the International AIDS Society #HIVunmuted podcast. In this latest episode, I discuss the latest #HIV science unveiled at #AIDS2024 & what it means for the #HIV response with our new host @juanmichaelii. 🎧Listen now! iasociety.org/podcast/12-gam…

#AIDS2024 Happening now. DZIF (inaktiv) sponsored session at the Global village: Bridging communities: Enhancing engagement through language in #HIV research

Is there a link between intimate partner violence (IPV) and HIV vertical transmission? This modelling analysis from Salome Kuchukhidze @Mat__MG and coauthors estimates that IPV might be responsible for one in eight paediatric #HIV infections in sub-Saharan Africa. thelancet.com/journals/lanhi…

Check out our e-poster, on a pilot of HIV self-testing distribution among tertiary education students in Zimbabwe TUPEE492 😀 #AIDS2024 #HIVselftest

Have you heard? The #GlobalAIDSUpdate2024 report is out! The new UNAIDS Global report highlights that world leaders, communities, and donors can achieve the goal of ending AIDS as a public health threat by 2030 by courageously providing the necessary resources and safeguarding

Young people were right at the forefront of designing, delivering, evaluating and disseminating CHIEDZA, a community-based, integrated HIV and sexual and reproductive health programme in Zimbabwe THRU_ZIM chiedza.co.zw #AIDS2024

"Young people are not difficult to engage... we haven't really made (HIV) programmes amenable to the barriers that they are facing" Rashida Abbas Ferrand #AIDS2024

📣 There are only two weeks to go until applications open to study in the UK on a fully funded #Chevening Scholarship! Start thinking about which courses you’d like to apply for today ⏰👇 chevening.org/courses #ChooseChevening #MyCheveningJourney

🇩🇪 Guten Morgen! We had a packed day yesterday with #AIDS2024 well and truly underway, and have another exciting one in store for day 3. 📨 Check out what to expect today and catch up on yesterday’s highlights in a new Daily Digest! iasociety.org/conferences/ai…

If we want to solve a lot of the problems with the HIV response (and the world more generally) our political leaders could do a lot worse than to start by listening to and acting on Helen Clark’s IAC - the International AIDS Conference plenary talk. #AIDS2024 #PutPeopleFirst

👏 Desmond Tutu Health Foundation’s Linda-Gail Bekker 🇿🇦 receives a standing ovation after presenting full results from the PURPOSE 1 study. The results confirm #lenacapavir demonstrated 100% efficacy for #HIV prevention in cisgender women.

If you are attending the #AIDS2024 in Munich, come swing by our poster track A 010 on #HIV specific follicular T cells @Tropeninstitut DZIF (inaktiv)

Great results on factors associated with undiagnosed #HIV in youths from Zimbabwe presented by the wonderful Leyla Larsson London School of Hygiene & Tropical Medicine THRU_ZIM #AIDS2024 @Tropeninstitut

And also had the opportunity to present our findings about HIV testing uptake in the context of CHIEDZA - a youth-friendly, community-based, and integrated SRH and HIV service! A privilege to be here and share these results at #AIDS2024 Rashida Abbas Ferrand THRU_ZIM

Rashida Abbas Ferrand #AIDS2024 RCT weekly vit D/daily calcium vs placebo in 11-19 yr olds with HIV Higher vit d levels but no impact on BMD overall but if vit D deficient (<75 nmol/L), significant BMD improvement Largest trial to date of vit D supplementation in children with HIV!!!!

Vitamin D (20,000iu weekly) and calcium (500mg daily) supplementation improves bone density in adolescents age 11-19 living with HIV in Zambia & Zimbabwe with 25OHD<75 - EDCTP VITALITY trial results presented by Rashida Abbas Ferrand IAC - the International AIDS Conference THRU_ZIM

Should analytic treatment interruption (ATI) be integrated into research related to the attainment of ART-free viral control in children with #HIV? This position paper examines current evidence, benefit–risk balance and design features for ATI trials. thelancet.com/journals/lanhi…

On this #WorldHumanitarianDay, we honor the dedicated researchers & health workers who tirelessly work to improve lives. Together, we build healthier futures for all, one study at a time. 🌍💪#GlobalHealth #HealthForAll #HumanitarianHeroes"

Over 200 participants joined the #VITALITYTrial dissemination event in Lusaka to engage with findings and reconnect with peers. A great moment of sharing, learning, and impact. Read more: vitality-trial.co.uk/post/over-200-…